SLDB peer analysis
Solid Biosciences (SLDB) against its competitors: price, today's move, 1-year return and market value side by side.
SLDB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CAPR Capricor | $9.82 | 9.11% | 57.88% | $570.92M |
| DYN Dyne Therapeutics | $18.63 | 3.10% | 2.33% | $3.49B |
| EWTX Edgewise Therapeutics | $48.74 | 8.21% | 185.20% | $5.34B |
| FDMT 4D Molecular | $12.47 | 1.80% | 14.19% | $688.90M |
| MGTX MeiraGTx | $9.48 | 5.39% | 12.78% | $910.97M |
| NGNE Neurogene | $26.04 | 2.88% | -2.33% | $521.10M |
| PASG Passage Bio | $3.98 | 14.88% | -38.94% | $12.79M |
| PEPG PepGen | $2.36 | -4.45% | -43.94% | $163.45M |
| PTCT PTC Therapeutics | $65.11 | -0.50% | -10.30% | $5.44B |
| SRPT Sarepta Therapeutics | $17.11 | -3.98% | -3.00% | $1.83B |
| SLDB Solid Biosciences | $7.01 | 6.45% | 66.43% | $782.95M |
- SLDB's peers: CAPR (Capricor), DYN (Dyne Therapeutics), EWTX (Edgewise Therapeutics), FDMT (4D Molecular), MGTX (MeiraGTx), NGNE (Neurogene), PASG (Passage Bio), PEPG (PepGen).
Updated 2026-11-10 04:45 UTC